Stock GALT GALECTIN THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Galectin Therapeutics Inc.

Equities

GALT

US3632252025

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
3.05 USD 0.00% Intraday chart for Galectin Therapeutics Inc. -5.57% +83.73%
May. 15 Galectin Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 29 Galectin Therapeutics Inc. Appoints Benjamin S. Carson as Member of the Board of Directors CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts Price Target on Galectin Therapeutics to $11 From $14, Reiterates Buy Rating
MT
GALECTIN THERAPEUTICS : HC Wainwright Adjusts Price Target on Galectin Therapeutics to $14 From $12, Maintains Buy Rating
MT
Galectin Therapeutics to Present at Berenberg NASH Day in New York
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GALT Stock
  4. News Galectin Therapeutics Inc.
  5. Analyst Reco.